Intra-Host Evolution of SARS-CoV-2 During Persistent Infection of Pediatric COVID-19 Patients
Charlie R Boyle1,2, Tien Doan2,3, Estefany Rios-Guzman2,3
1Division of Pediatric Infectious Diseases, Anne and Robert H. Lurie Children's Hospital, Chicago, IL 60611, USA.
Insights
Children with COVID-19 show similar SARS-CoV-2 evolution during persistent infections as adults. This suggests pediatric cases contribute to viral diversification and the emergence of new variants.
Area of Science:
- Virology
- Immunology
- Pediatrics
Background:
- Coronavirus disease 2019 (COVID-19) presents differently in children than adults, often with milder symptoms.
- Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can lead to viral evolution and immune escape, particularly in adults.
- The evolutionary dynamics of SARS-CoV-2 during persistent infection in children remain less understood.
Purpose of the Study:
- To investigate the intra-host evolution of SARS-CoV-2 in pediatric COVID-19 patients.
- To compare viral evolution in immunocompetent versus immunocompromised children.
- To determine if children contribute to viral diversification and the emergence of new variants.
Main Methods:
- Whole genome sequencing of longitudinal SARS-CoV-2 specimens from pediatric patients.
- Analysis of viral mutations and intra-host diversity.
- Comparison of evolutionary trends between immunocompetent and immunocompromised children.
Main Results:
- Mutations conferring viral fitness and immune escape emerged within hosts over time in pediatric patients.
- Intra-host diversity accumulated at comparable rates in both immunocompetent and immunocompromised children.
- Immunocompromised children had more overall mutations due to longer infection durations.
Conclusions:
- SARS-CoV-2 exhibits similar evolutionary trends during persistent infection in children as observed in adults.
- Persistent infection in children represents a potential source of viral diversification.
- Understanding pediatric viral evolution is crucial for managing COVID-19 and anticipating future variants.
Abstract:
The Coronavirus disease 2019 (COVID-19) pandemic had a profound global impact, yet children exhibited distinct clinical and epidemiological patterns compared to adults. Pediatric cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were generally characterized by milder disease, lower hospitalization rates, and few long-term sequelae. However, a subset of children developed severe complications such as multisystem inflammatory syndrome in children (MIS-C), highlighting the heterogeneity in disease presentation. Differences in immune system maturity and comorbidities likely contribute to the age-dependent manifestation of SARS-CoV-2 and other respiratory viruses. Persistent SARS-CoV-2 infection, particularly in immunocompromised individuals, has been implicated in the emergence of new viral variants with immune escape characteristics due to ongoing viral replication in the presence of selective pressure. While SARS-CoV-2 evolution in persistently infected adults has been well-documented, it is less clear how the virus evolves during persistent infection in the pediatric population. To address this question, we performed viral whole genome sequencing of longitudinal specimens collected from immunocompetent and immunocompromised pediatric COVID-19 patients. Similarly to what has been observed in adult cohorts, mutations associated with enhanced viral fitness and immune escape arose intra-host over time. Intra-host diversity accumulated at similar rates in immunocompetent and immunocompromised children, though more mutations overall were observed in the immunocompromised cohort due to the longer infection time courses. Overall, we identified similar viral evolutionary trends over the course of infection despite clinical differences in pediatric COVID-19 manifestation and severity. This similarity suggests that persistent infection in children may be an additional, but not unique, source of ongoing viral diversification.
Related Concept Videos
Pneumonia II: Pathophysiology
Stages of Infection
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Viral Mutations
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Pharmacokinetics in Pediatric Patients: Drug Excretion


